- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Stop using these cough syrups immediately, warns Telangana Drug Authority

Telangana: The Drugs Control Administration, Telangana, has issued an urgent public alert advising citizens to immediately stop using two cough syrups found adulterated with Diethylene Glycol (DEG)—a highly toxic subtance.
The alert follows a report from the Drug Testing Laboratory, Government of Madhya Pradesh, Bhopal, which detected the presence of DEG in the following syrups:
1. “Relife” Cough Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup)
o Batch No.: LSL25160
o Expiry Date: 12/2026
o Manufactured By: M/s. Shape Pharma Pvt. Ltd., Plot No. 4, Shekhpar – 363510, Gujarat
2. “Respifresh TR” Cough Syrup (Bromhexine Hydrochloride, Terbutaline Sulphate, Guaiphenesin & Menthol Syrup)
o Batch No.: R01GL2523
o Expiry Date: 12/2026
o Manufactured By: M/s. Rednex Pharmaceuticals Pvt. Ltd., Survey No. 586 & 231, Near SKF Bearing, Bavla–Bagodara N.H. 8A, Taluka Bavla, District Ahmedabad, Gujarat – 383220
The DCA has directed all Drugs Inspectors and Assistant Directors across Telangana to immediately alert retailers, distributors, and hospitals to freeze stocks of the said product batches and ensure that the same are not dispensed or sold under any circumstances.
Citizens in possession of these products have been urged to report them to the nearest Drugs Control Authority without delay or report possession of the said products directly to the Drugs Control Administration, Telangana.
Read also: Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co
"The Drugs Control Administration, Telangana, has initiated necessary enforcement measures and is actively monitoring the situation to prevent further risk to public health. The public is urged to exercise utmost caution and refrain from using the aforementioned products to avert any potential health hazards associated with Diethylene Glycol toxicity," the administration stated.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751